Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/30/1996 | EP0739353A1 Bacterial receptor structures |
10/30/1996 | EP0739352A1 New composition of glycoprotein isoforms having follicle stimulating activity |
10/30/1996 | EP0739350A1 Ligand that binds fas antigen |
10/30/1996 | EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
10/30/1996 | EP0739212A1 Use of interleukin-12 to prevent graft versus host disease |
10/30/1996 | EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
10/30/1996 | EP0647277A4 Methods for using cks fusion proteins. |
10/30/1996 | EP0592476B1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action |
10/30/1996 | EP0527852B1 Method and compositions for treating injury |
10/30/1996 | EP0512071B1 Method and compositions for inhibiting angiogenesis |
10/30/1996 | EP0487613B1 A megakaryocytopoietic factor |
10/30/1996 | EP0479909B1 Bispecific reagents for aids therapy |
10/30/1996 | CN1134728A Subtilisin BPN' variants with decreased adsorption and increased hydrolysis |
10/30/1996 | CN1134707A Peptide and antithrombotic agent |
10/30/1996 | CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
10/30/1996 | CN1134704A Drug binding protein |
10/30/1996 | CN1134461A Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing said RHDV recombinant capsids and proteins |
10/30/1996 | CN1134460A HTFIIIA gent |
10/29/1996 | US5569830 Plant inhibitors of fungal polygalacturonases and their use to control fungal disease |
10/29/1996 | US5569829 Sense or antisense rna technology to control gene expression, increased solids contents |
10/29/1996 | US5569828 Maize chlorotic dwarf virus and resistance thereto |
10/29/1996 | US5569827 Transgenic mouse for the neuronal expression of HIV gp160 |
10/29/1996 | US5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
10/29/1996 | US5569824 Tumor susceptible |
10/29/1996 | US5569823 DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance |
10/29/1996 | US5569768 Angiotensin II antagonists |
10/29/1996 | US5569755 Antitumor agents |
10/29/1996 | US5569744 A modified polypeptide; reduced risk for diabetes type ii, cardiovascular disorder and cancer; regulates fat tissues |
10/29/1996 | US5569743 Anti-obesity proteins |
10/29/1996 | US5569742 Centrally truncated NPY cyclic peptides |
10/29/1996 | US5569741 Cyclic octapeptide neuromedin B receptor antagonists |
10/29/1996 | US5569680 Administering to inhibit the production of interleukin-8 in intestinal epithelial cells |
10/29/1996 | US5569647 Angiopeptin cyclopeptide compounds |
10/29/1996 | US5569604 Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins |
10/29/1996 | US5569603 Parasiticide |
10/29/1996 | US5569601 Human dopamine receptor and its uses |
10/29/1996 | US5569598 Extracellular aminopeptidase isolated from Streptococcus thermonitrificans culture |
10/29/1996 | US5569595 Production of poly-β-hydroxybutyrate in prokaryotic host cells |
10/29/1996 | US5569584 Method for distinguishing or monitoring the state of premalignant or malignant transformed human colonic tissue |
10/29/1996 | US5569454 Methods of treating infection using natural killer stimulatory factor |
10/29/1996 | CA2175115A1 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same |
10/29/1996 | CA1338682C Biologically active undenatured whey protein concentrate as food supplement |
10/25/1996 | EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it |
10/24/1996 | WO1996033416A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
10/24/1996 | WO1996033414A2 Compounds and methods for diagnosis of leishmaniasis |
10/24/1996 | WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/24/1996 | WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
10/24/1996 | WO1996033278A1 New cathepsin c homolog |
10/24/1996 | WO1996033276A1 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
10/24/1996 | WO1996033275A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE |
10/24/1996 | WO1996033274A1 Helicobacter pylori cagi region |
10/24/1996 | WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
10/24/1996 | WO1996033272A1 Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby |
10/24/1996 | WO1996033271A2 Genetic markers for breast and ovarian cancer |
10/24/1996 | WO1996033270A1 Structure-based designed herbicide resistant products |
10/24/1996 | WO1996033269A1 Vectors and prokaryotes which autocatalytically delete antibiotic resistance |
10/24/1996 | WO1996033220A1 Protective helicobacter antigens |
10/24/1996 | WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
10/24/1996 | WO1996033218A1 Anti-haemorrhagic peptides |
10/24/1996 | WO1996033217A1 Cell adhesion protein, immunosuppressive agent containing the same, and immunosuppressive agent containing cells induced thereby |
10/24/1996 | WO1996033216A1 Truncated igf-i |
10/24/1996 | WO1996033215A1 Novel protein and process for producing the same |
10/24/1996 | WO1996033214A2 Altered protein expression in hypoxic trophoblasts |
10/24/1996 | WO1996033206A1 Conotoxin peptides |
10/24/1996 | WO1996032963A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
10/24/1996 | WO1996032962A1 Immunoassay for herpes simplex virus |
10/24/1996 | WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
10/24/1996 | WO1996032958A1 Method for treatment of pain |
10/24/1996 | WO1996032957A1 Modulation of cytokine patterns of human autoreactive t-cell clones |
10/24/1996 | WO1996032956A1 p19: A CELL CYCLE INHIBITOR |
10/24/1996 | WO1996032955A1 Neuropeptide y analogs |
10/24/1996 | WO1996032954A1 Nitrosylated neuropeptides |
10/24/1996 | WO1996032932A1 Dna vaccines against rotavirus infections |
10/24/1996 | WO1996032841A1 Novel therapeutic binding molecule complexes |
10/24/1996 | WO1996028549A3 Hyaluronan receptor expressed in human umbilical vein endothelial cells |
10/24/1996 | WO1996027128A3 Hiv determinants required for in vivo replication |
10/24/1996 | WO1996020278A3 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
10/24/1996 | WO1996016982A3 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
10/24/1996 | WO1996011562A3 Human checkpoint gene and gene for antisense rna thereof |
10/24/1996 | DE19515327A1 Antitumour agents comprising new poly:peptide(s) |
10/24/1996 | DE19514310A1 Vektoren zur Transfektion von eukaryotischen Zellen, deren Verwendung und damit transfizierte Zielzellen Vectors for transfection of eukaryotic cells, their use and thus transfected target cells |
10/24/1996 | CA2218741A1 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof |
10/24/1996 | CA2218691A1 Novel therapeutic binding molecule complexes |
10/24/1996 | CA2218618A1 Method for treatment of pain |
10/24/1996 | CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
10/24/1996 | CA2218585A1 H. influenzae hxub and hxuc genes, proteins and methods of use |
10/24/1996 | CA2218535A1 Altered protein expression in hypoxic trophoblasts |
10/24/1996 | CA2218385A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
10/24/1996 | CA2217496A1 Protective helicobacter antigens |
10/24/1996 | CA2217010A1 New cathepsin c homolog |
10/24/1996 | CA2216936A1 Modulation of cytokine patterns of human autoreactive t-cell clones |
10/24/1996 | CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/24/1996 | CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
10/24/1996 | CA2216751A1 Conotoxin peptides |
10/23/1996 | EP0738736A1 Monoclonal antibodies to gp130, and their uses |
10/23/1996 | EP0738735A2 Aminoterminal propeptide of type I procollagen, antibody thereto and assay method using it |
10/23/1996 | EP0738734A1 NOVEL RECOMBINANT DerI ALLERGENIC SUBSTANCE, PRECURSOR THEREOF, AND PROCESS FOR PRODUCING THEM |
10/23/1996 | EP0738332A1 Indicator cell line for detecting rna viruses and method therefor |
10/23/1996 | EP0738329A1 Hybrid cytokines |
10/23/1996 | EP0738325A1 Receptor specific bacterial adhesins and their use |